Anyone continuing to sell mass-compounded tirzepatide, including by referring to it as personalized, tailored or something similar, is breaking the law and putting patients at risk. Lilly and others have started suing pharmacies that continue to make them
Free registration is available now
Long-term GLP-1 therapy is safe and increasingly recognized as chronic weight management treatment, similar to how diabetes medications are used indefinitely
Everyones talking about them for weight loss and diabetes
Jorgensen R, Martini L, Schwartz TW, Elling CE
Some complaints also reference other serious complications, including deep vein thrombosis, though gastrointestinal motility conditions remain the primary focus in many GLP-1 filings